Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06777576 · ClinicalTrials.gov registry record · NA

Self-balancing Personal Exoskeleton for SCI

A NA study of Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, sponsored by Wandercraft.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06777576: Recruiting NA study of Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, sponsored by Wandercraft.

NCT06777576 is a NA study of Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia that is actively recruiting participants, run by Wandercraft. The registered enrollment target is 24 participants, below the 65-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06777576, a NA study of Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, is actively recruiting participants, sponsored by Wandercraft.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Primary Outcome

The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.

Interventions

  • DEVICE Hands-free exoskeleton

Study Locations (1)

New York

  • James J. Peters, VA Medical Center, Bronx, NY - The Bronx

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-02-12
Est. Completion 2026-05-31
Phase NA
Wandercraft

5 total trials

What NCT06777576 shows while recruiting

NCT06777576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 65-participant average among 9 other Spinal Cord Injuries (SCI) trials with a reported enrollment target (63% lower).

The record links to 2 conditions, with Spinal Cord Injuries (SCI) appearing as the primary indexed condition, and to 1 intervention - of which Hands-free exoskeleton is the first listed.

NCT06777576 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06777576 about?

NCT06777576 is a clinical study titled "Self-balancing Personal Exoskeleton for SCI". This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

What is the current status of trial NCT06777576?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-02-12. Estimated completion is 2026-05-31.

What conditions does trial NCT06777576 study?

This clinical trial studies the following conditions: Spinal Cord Injuries (SCI), Paraplegia and Tetraplegia.

What interventions are being tested in trial NCT06777576?

The interventions under investigation include: Hands-free exoskeleton (DEVICE).

Who is sponsoring clinical trial NCT06777576?

This trial is sponsored by Wandercraft, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06777576 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries (SCI)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06777576's enrollment target sits among peer trials

24 7th of 9 higher than 2 of 9 other Spinal Cord Injuries (SCI) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries (SCI) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06777576, the US trial registry maintained by the National Library of Medicine. NCT06777576 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.